Author:
Garman Elspeth,Laver Graeme
Reference50 articles.
1. Air, G.M. and Laver, W.G. (1986). The molecular basis of antigenic variation in influenza virus. Adv. Virus Res. 31, 53–102.
2. Atassi, M.Z. (1980). Molecular immune recognition of proteins: The precise determination of protein antigenic sites has led to synthesis of antibody combining sites and other types of protein binding sites. In Laver, W.G. and Air, G.M. (eds.), Structure and Variation in Influenza Virus, Elsevier North Holland, Inc, pp. 241–271.
3. Babu, Y.S., Chand, P., Banta, S., Kotian, P., Dehghani, A., El-Katan, Y. et al. (2000). BCX-1812 (RWJ-27021). Discovery of a novel, highly potent, orally active and selective influenza virus neuraminidase inhibitor through structure-based drug design. J. Med. Chem. 43, 3482–3486.
4. Baker, A.T., Varghese, J.N. Laver, W.G. Air, G.M. and Colman, P.M. (1987). Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2, 111–117.
5. Blow, D. (2002). Outline of Crystallography for Biologists. OUP, Oxford, United Kingdom. 0198510519
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献